Governor's Executive Order targets eugenics and sterilization program
By Loretta Arnold,
Examiner.com [Raleigh]
| 03. 17. 2011
[North Carolina]
North Carolina Governor Bev Perdue sends a Task Force message within Executive Order No. 83 involving the North Carolina Eugenics Board's sterilization program. The program was designed to select human breeding by sterilization involving adults and young children between the years of 1929 and 1974. EO: No. 83 delivers the tools in reaching the long needed three C's for a sterilization victim and their family - closure, compensation and counseling.
Governor Perdue will appoint five Task Force members; one former judge, one physician, one former journalist, one historian, and an attorney with experience in the health insurance field or with a medical ethics background as described in the EO. The Task Force is expected to complete a preliminary report by August 1, 2011 and a final report by February 1, 2012. EO: 83 was signed by both Governor Perdue and Secretary of State Elaine F. Marshall on March 8.
For more read North Carolina's
Executive Order No. 83 [PDF].
The eugenics program was developed in 1933 as a part of the Department of Public Welfare - the "modern day Division...
Related Articles
By Anna Louie Sussman, The New York Times | 08.21.2026
Since in vitro fertilization was invented nearly 50 years ago, at least 10 million children who would not otherwise exist have been brought into the world. New constellations of families — older moms, same-sex parents, single dads — have flourished...
By Jenni Fink, Newsweek | 08.19.2026
“Donald Trump” by Gage Skidmore is licensed under CC BY-SA 2.0
President Donald Trump's latest effort to limit birthright citizenship could have consequences for the international surrogacy industry, potentially affecting thousands of intended parents from overseas who travel...
By Claire Robinson and Jonathan Matthews, Guest Contributors
| 08.25.2026
This is an excerpt of an article originally published on August 1, 2026 at GMWatch.
A six-year-old girl has died in a gene editing gene therapy trial in China that went wrong, the journal Science reports. Seven days after the girl's medical team infused trillions of viruses carrying the recipe for the gene editing tool – in this case a base editor – into her spinal fluid, she died of a severe immune reaction linked to the therapy.
Just...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...